Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 5,990,000 shares, a growth of 7.5% from the October 15th total of 5,570,000 shares. Based on an average trading volume of 1,480,000 shares, the short-interest ratio is currently 4.0 days.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC increased its position in Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after acquiring an additional 14,197 shares during the period. Y Intercept Hong Kong Ltd grew its stake in shares of Acadia Healthcare by 40.6% in the third quarter. Y Intercept Hong Kong Ltd now owns 36,605 shares of the company’s stock worth $2,321,000 after purchasing an additional 10,572 shares in the last quarter. Orion Portfolio Solutions LLC increased its holdings in shares of Acadia Healthcare by 12.5% during the third quarter. Orion Portfolio Solutions LLC now owns 18,166 shares of the company’s stock valued at $1,152,000 after purchasing an additional 2,013 shares during the period. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. Finally, State Street Corp grew its position in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC opened at $37.82 on Friday. Acadia Healthcare has a 12 month low of $37.78 and a 12 month high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a fifty day moving average price of $58.05 and a 200 day moving average price of $65.60. The company has a market cap of $3.51 billion, a P/E ratio of 12.40, a PEG ratio of 1.76 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 earnings per share. On average, research analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

ACHC has been the subject of several recent analyst reports. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays decreased their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.